1h Free Analyst Time
The publisher has been monitoring the animal biotechnology market and it is poised to grow by $3.26 bn during 2022-2026, progressing at a CAGR of 2.82% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing growth strategies of market players and growing focus toward animal cloning.
The animal biotechnology market analysis includes the product segment and geographic landscape.
The animal biotechnology market is segmented as below:
By Product
- Drug
- Vaccine
- Diagnostic test
- Others
By Geography
- North America
- Europe
- APAC
- South America
- MEA
This study identifies the use of transgenic animals to produce recombinant proteins as one of the prime reasons driving the animal biotechnology market growth during the next few years.
The report on animal biotechnology market covers the following areas:
- Animal biotechnology market sizing
- Animal biotechnology market forecast
- Animal biotechnology market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal biotechnology market vendors that include Bayer AG, Boehringer Ingelheim International GmbH, Heska Corp., Id Vet India Pvt. Ltd., IDEXX Laboratories Inc., Merck and Co. Inc., Pfizer Inc., Santa Cruz Biotechnology Inc., Virbac Group, and Zoetis Inc. Also, the animal biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Drug - Market size and forecast 2021-2026
- Vaccine - Market size and forecast 2021-2026
- Diagnostic test - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by Product
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- APAC - Market size and forecast 2021-2026
- South America - Market size and forecast 2021-2026
- MEA - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive landscape
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Bayer AG
- Boehringer Ingelheim International GmbH
- Heska Corp.
- Id Vet India Pvt. Ltd.
- IDEXX Laboratories Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Santa Cruz Biotechnology Inc.
- Virbac Group
- Zoetis Inc.
- Zoetis Inc. - Segment focus
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Product - Market share 2021-2026 (%)
- Comparison by Product
- Drug - Market size and forecast 2021-2026 ($ million)
- Drug - Year-over-year growth 2021-2026 (%)
- Vaccine - Market size and forecast 2021-2026 ($ million)
- Vaccine - Year-over-year growth 2021-2026 (%)
- Diagnostic test - Market size and forecast 2021-2026 ($ million)
- Diagnostic test - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ($ million)
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Product
- Customer landscape
- Market share by geography 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- APAC - Market size and forecast 2021-2026 ($ million)
- APAC - Year-over-year growth 2021-2026 (%)
- South America - Market size and forecast 2021-2026 ($ million)
- South America - Year-over-year growth 2021-2026 (%)
- MEA - Market size and forecast 2021-2026 ($ million)
- MEA - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity by geography ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Business segments
- Boehringer Ingelheim International GmbH - Key offerings
- Boehringer Ingelheim International GmbH - Key customers
- Boehringer Ingelheim International GmbH - Segment focus
- Heska Corp. - Overview
- Heska Corp. - Business segments
- Heska Corp. - Key offerings
- Heska Corp. - Key customers
- Heska Corp. - Segment focus
- Id Vet India Pvt. Ltd. - Overview
- Id Vet India Pvt. Ltd. - Product and service
- Id Vet India Pvt. Ltd. - Key offerings
- Id Vet India Pvt. Ltd. - Key customers
- Id Vet India Pvt. Ltd. - Segment focus
- IDEXX Laboratories Inc. - Overview
- IDEXX Laboratories Inc. - Business segments
- IDEXX Laboratories Inc. - Key offerings
- IDEXX Laboratories Inc. - Key customers
- IDEXX Laboratories Inc. - Segment focus
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Key customers
- Merck and Co. Inc. - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Santa Cruz Biotechnology Inc. - Overview
- Santa Cruz Biotechnology Inc. - Product and service
- Santa Cruz Biotechnology Inc. - Key offerings
- Santa Cruz Biotechnology Inc. - Key customers
- Santa Cruz Biotechnology Inc. - Segment focus
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Key customers
- Virbac Group - Segment focus
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Key customers
- Zoetis Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global animal biotechnology market: Bayer AG, Boehringer Ingelheim International GmbH, Heska Corp., Id Vet India Pvt. Ltd., IDEXX Laboratories Inc., Merck and Co. Inc., Pfizer Inc., Santa Cruz Biotechnology Inc., Virbac Group, and Zoetis Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is use of transgenic animals to produce recombinant proteins.'
According to the report, one of the major drivers for this market is the increasing growth strategies of market players.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Boehringer Ingelheim International GmbH
- Heska Corp.
- Id Vet India Pvt. Ltd.
- IDEXX Laboratories Inc.
- Merck and Co. Inc.
- Pfizer Inc.
- Santa Cruz Biotechnology Inc.
- Virbac Group
- Zoetis Inc.